Scientific Updates on Antiplatelet Therapies for the Management of Patients with Acute Coronary Syndrome

Program Overview

This continuing education activity will highlight recent advances in antiplatelet therapeutics for acute coronary syndrome. The expert faculty will analyze current guidelines and provide insight into best approaches for developing effective patient-specific treatment plans that include the clinical pharmacy team. Navigating combination therapies while optimizing duration of antiplatelet therapies in the ACS patient will be reviewed in an interactive panel format. The faculty will also discuss the role of the pharmacist in the cardiac catheterization laboratory, covering procedural best practices, medication reconciliation, and patient education. This activity will provide learners with a better understanding of acute coronary syndrome and the central role of platelet inhibition during early management, particularly in the cath lab, to improve treatment and management in their pharmacy practice.

Target Audience

Pharmacists, cardiologists, primary care physicians, PAs, NPs, nurses, and other healthcare professionals involved in the management of patients with ACS

Agenda

I. A Review of Updated Guidelines for Antiplatelet Therapies for ACS to Develop Effective Patient-Specific Treatment Plans

• Upstream Oral Therapy vs. Oral Therapy on the Table
• Intravenous Antithrombotic Therapies in the Drug Shortage Era-Emergency Department, Catheterization Lab Options
• Best Approaches for STEMI vs. NSTE-ACS
• Differences between ACC/AHA and ESC ACS Guidelines

II. A Clinical Analysis of the Latest Antiplatelet Agent Data for the Treatment of Patients with ACS

• Determining Optimal Combinations of Antithrombotic agents in ACS patients
• Optimizing the Duration of Antiplatelet therapy in the ACS patient

III. Identifying a Pharmacist Role in the Cardiac Catheterization Laboratory

• Review of national and international Best Practice Standards (Society for Cardiovascular Angiography and Interventions Intersocietal Accreditation Commission for Cardiac Catheterization)
• Cardiac Catheterization Pre and Post Procedure Check list and Emergency Preparedness (medications, lab testing, co-morbidities)
• Medication reconciliation and patient instruction

Faculty

 John Fanikos, RPh, MBA (Course Chair)
Brigham and Women’s Hospital
Boston, Massachusetts

Snehal H. Bhatt, PharmD
Professor of Pharmacy Practice
MCPHS University
Clinical Pharmacist
Beth Israel Deaconess Medical Center
Boston, Massachusetts 

Charles V. Pollack, Jr., MA, MD
Founding Board Member
Hospital Quality Foundation
Shrewsbury, New Jersey

Accreditation Statement

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation Statements

AcademicCME designates this live material for a maximum of 1.50 AMA PRA Category 1 Credits^TM.

AcademicCME designates this live material for a maximum of 1.50 CNE contact hours (Provider number P0491).

AcademicCME designates this continuing education activity for 1.50 CPE contact hours (0.15 CEU) of continuing pharmacy education credit (UAN # JA4008190-0000-19-007-L01-P).

Participants should claim only the credit commensurate with the extent of their participation in the activity.

CE Inquiries/Special Needs

For all CE inquiries or special needs, please contact [email protected] or 610-687-3300.

Financial Support

This activity has been supported by an independent educational grant from Chiesi USA, Inc.

Provided by AcademicCME

 

 

* This symposium is neither sponsored nor endorsed by the 2019 ASHP Midyear Clinical Meeting & Exhibition.

---